Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension, February 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 155 articles:
HTML format


 

Single Articles

  1. VAIYANI D, Kelleman M, Downey LA, Kanaan U, et al
    Risk Factors for Adverse Events in Children with Pulmonary Hypertension Undergoing Cardiac Catheterization.
    Pediatr Cardiol. 2021 Jan 29. pii: 10.1007/s00246-020-02535.
    PubMed    
    Abstract available

  2. GHOSH MC, Zhang D, Ollivierre H, Noguchi A, et al
    Therapeutic inhibition of HIF2alpha reverses polycythemia and pulmonary hypertension in murine models of two human diseases.
    Blood. 2020 Dec 17. pii: 474743. doi: 10.1182/blood.2020009138.
    PubMed    
    Abstract available

  3. CHEN CY, Wu WT, Wang YL, Liao KM, et al
    Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease.
    Front Pharmacol. 2021;11:613761.
    PubMed    
    Abstract available

  4. YADAV RK, Dhungel BK, Hamal PK, Pokhrel N, et al
    Anaesthesia for Antenatal Diagnosed Duodenal Atresia with Undiagnosed Persistent Pulmonary Hypertension of Neonate.
    J Nepal Health Res Counc. 2021;18:792-794.
    PubMed    
    Abstract available

  5. DOMINGO E, Perez Hoyos S, Grignola JC
    Pulmonary hypertension due to chronic pulmonary thromboembolism. An evolving disease.
    Rev Esp Cardiol (Engl Ed). 2021 Jan 25. pii: S1885-5857(21)00019.
    PubMed    


  6. ZVIRBLYTE R, Montvilaite A, Tamulenaite E, Saniukaite A, et al
    Echocardiographic predictors of exercise induced pulmonary hypertension in patients with asymptomatic moderate to severe mitral regurgitation and preserved left ventricular ejection fraction.
    Perfusion. 2021 Jan 28:267659120987545. doi: 10.1177/0267659120987545.
    PubMed    
    Abstract available

  7. CAPONE C, Valentini A, Spinillo SL, Klersy C, et al
    Radiological differences between chronic thromboembolic pulmonary disease (CTEPD) and chronic thromboembolic pulmonary hypertension (CTEPH).
    Eur Radiol. 2021 Jan 28. pii: 10.1007/s00330-020-07556.
    PubMed    
    Abstract available

  8. GUPTA S, Agrawal G, Balde M, Wazir S, et al
    Surfactant dysfunction disorder masquerading as meconium aspiration syndrome and persistent pulmonary hypertension of the newborn.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  9. BARATTO C, Caravita S, Battista Perego G, Badano LP, et al
    Systemic Sclerosis and Pulmonary Hypertension: The Great Masquerader.
    Circ Heart Fail. 2021 Jan 28:CIRCHEARTFAILURE120007554.
    PubMed    


  10. RAI N, Shihan M, Seeger W, Schermuly RT, et al
    Genetic Delivery and Gene Therapy in Pulmonary Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  11. LACOSTE PALASSET T, Chaumais MC, Weatherald J, Savale L, et al
    Association between Leflunomide and Pulmonary Hypertension.
    Ann Am Thorac Soc. 2021 Jan 26. doi: 10.1513/AnnalsATS.202008.
    PubMed    
    Abstract available

  12. SANDFORT V, Bluemke DA
    CT of the Heart: Expanding Clinical Applications in Pulmonary Hypertension.
    Radiology. 2021 Jan 26:204468. doi: 10.1148/radiol.2021204468.
    PubMed    


  13. ZIELINSKY P, Magalhaes GA, Zurita-Peralta J, Sosa-Olavarria A, et al
    Improvement of fetal pulmonary hypertension and maturity after reversal of ductal constriction: a prospective cohort study.
    Ultrasound Obstet Gynecol. 2021 Jan 27. doi: 10.1002/uog.23599.
    PubMed    
    Abstract available

  14. KARPOV AA, Anikin NA, Mihailova AM, Smirnov SS, et al
    Model of Chronic Thromboembolic Pulmonary Hypertension in Rats Caused by Repeated Intravenous Administration of Partially Biodegradable Sodium Alginate Microspheres.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  15. FRUMP AL, Albrecht ME, Yakubov B, Breuils Bonnet S, et al
    17beta-estradiol and estrogen receptor-alpha protect right ventricular function in pulmonary hypertension via BMPR2 and apelin.
    J Clin Invest. 2021 Jan 26. pii: 129433. doi: 10.1172/JCI129433.
    PubMed    
    Abstract available

  16. YAMASAKI Y, Abe K, Kamitani T, Sagiyama K, et al
    Right Ventricular Extracellular Volume with Dual-Layer Spectral Detector CT: Value in Chronic Thromboembolic Pulmonary Hypertension.
    Radiology. 2021 Jan 26:203719. doi: 10.1148/radiol.2020203719.
    PubMed    
    Abstract available

  17. JANG AJ, Chang SS, Park C, Lee CM, et al
    PPARgamma increases HUWE1 to attenuate NF-kappaB/p65 and sickle cell disease with pulmonary hypertension.
    Blood Adv. 2021;5:399-413.
    PubMed    
    Abstract available

  18. KHAN NA, Ahuja KA, Wang X, Chaisson NF, et al
    Evaluation of hemodynamic parameters among patients with myeloproliferative neoplasms and suspected pulmonary hypertension.
    Leuk Lymphoma. 2021 Jan 25:1-14. doi: 10.1080/10428194.2020.1864351.
    PubMed    
    Abstract available

  19. MORALES-CANO D, Barreira B, Navarro BO, Callejo M, et al
    Oxygen-sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension.
    Antioxidants (Basel). 2021;10.
    PubMed    
    Abstract available

  20. CHOI WK, Kim J, Choi HJ, Hong SH, et al
    Fatal intracardiac and pulmonary arterial thromboembolic damage following ABO-incompatible living donor liver transplantation for autoimmune hepatitis: A case report.
    Medicine (Baltimore). 2021;100:e24298.
    PubMed    
    Abstract available

  21. YIN X, Xin M, Ding S, Gao F, et al
    Predictive role of perioperative neutrophil to lymphocyte ratio in pediatric congenital heart disease associated with pulmonary arterial hypertension.
    BMC Surg. 2021;21:3.
    PubMed    
    Abstract available

  22. MAGOON R, ItiShri, Kohli JK, Kashav R, et al
    Inhaled milrinone for sick COVID-19 cohort: A pathophysiology driven hypothesis!
    Med Hypotheses. 2021;146:110441.
    PubMed    


  23. CONTALDI C, Capuano F, Romano L, Ranieri B, et al
    Cardiovascular Magnetic Resonance in Right Heart and Pulmonary Circulation Disorders.
    Heart Fail Clin. 2021;17:57-75.
    PubMed    
    Abstract available

  24. RUBIO-RIVAS M, Homs NA, Cuartero D, Corbella X, et al
    The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: Systematic review and meta-analysis.
    Autoimmun Rev. 2021;20:102713.
    PubMed    
    Abstract available

  25. JIANG C, Li H, Zhang T
    A Man in His 90s With Progressive Hoarseness-What is the Cause?
    JAMA Cardiol. 2020;5:e205116.
    PubMed    


  26. PRAPAN N, Ratanasit N, Karaketklang K
    Significant functional tricuspid regurgitation portends poor outcomes in patients with atrial fibrillation and preserved left ventricular ejection fraction.
    BMC Cardiovasc Disord. 2020;20:433.
    PubMed    
    Abstract available

  27. ZUBIETA-CALLEJA G, Zubieta-DeUrioste N, Venkatesh T, Das KK, et al
    COVID-19 and Pneumolysis Simulating Extreme High-altitude Exposure with Altered Oxygen Transport Physiology; Multiple Diseases, and Scarce Need of Ventilators: Andean Condor's-eye-view.
    Rev Recent Clin Trials. 2020;15:347-359.
    PubMed    
    Abstract available

  28. LI M, Jing ZC, Li Y, Huo Y, et al
    Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis.
    BMC Cardiovasc Disord. 2020;20:339.
    PubMed    
    Abstract available

  29. LAU YM, Tse HF
    A Woman in Her 50s With Dyspnea, Palpitation, and Severely Elevated Pulmonary Artery Pressure.
    JAMA Cardiol. 2020;5:842.
    PubMed    


  30. SCHURMAN AM, Cain MT, Joyce DL, Durham LA, et al
    Minimally Invasive Mechanical Circulatory Support Through the Perioperative Pulmonary Thromboendarterectomy Period: A Case Report.
    Innovations (Phila). 2020;15:173-176.
    PubMed    
    Abstract available

  31. MULVANEY EP, Reid HM, Bialesova L, Bouchard A, et al
    NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
    BMC Pulm Med. 2020;20:85.
    PubMed    
    Abstract available

  32. WANG XJ, Xu XQ, Sun K, Liu KQ, et al
    Association of Rare PTGIS Variants With Susceptibility and Pulmonary Vascular Response in Patients With Idiopathic Pulmonary Arterial Hypertension.
    JAMA Cardiol. 2020;5:677-684.
    PubMed    
    Abstract available

  33. KUBO S, Siebuhr AS, Bay-Jensen AC, Juhl P, et al
    Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis.
    Int J Rheum Dis. 2020;23:532-539.
    PubMed    
    Abstract available

  34. OMORI A, Goshima M, Kakuda C, Kodama T, et al
    Chemerin-9-induced contraction was enhanced through the upregulation of smooth muscle chemokine-like receptor 1 in isolated pulmonary artery of pulmonary arterial hypertensive rats.
    Pflugers Arch. 2020;472:335-342.
    PubMed    
    Abstract available

  35. INGRAHAM NE, Tignanelli CJ, Menk J, Chipman JG, et al
    Pre- and Peri-Operative Factors Associated with Chronic Critical Illness in Liver Transplant Recipients.
    Surg Infect (Larchmt). 2020;21:246-254.
    PubMed    
    Abstract available

  36. GHOFRANI HA, Gomez Sanchez MA, Humbert M, Pittrow D, et al
    Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
    Respir Med. 2020;178:106220.
    PubMed    
    Abstract available

  37. REVERCOMB L, Hanmandlu A, Wareing N, Akkanti B, et al
    Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS).
    Front Mol Biosci. 2021;7:624093.
    PubMed    
    Abstract available

  38. YANG Z, Sun H, Su S, Nan X, et al
    Tsantan Sumtang Restored Right Ventricular Function in Chronic Hypoxia-Induced Pulmonary Hypertension Rats.
    Front Pharmacol. 2021;11:607384.
    PubMed    
    Abstract available

  39. TANABE N, Kumamaru H, Tamura Y, Taniguchi H, et al
    Multi-Institutional Prospective Cohort Study of Patients With Pulmonary Hypertension Associated With Respiratory Diseases.
    Circ J. 2021 Feb 2. doi: 10.1253/circj.CJ-20-0939.
    PubMed    
    Abstract available

  40. SU H, Chen EG, Wu XH, Ying KJ, et al
    [Research progress of non-coding RNA in pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:136-142.
    PubMed    


  41. DENTON CP, Spierings J
    Combining datasets as well as therapies shows improved outcome in connective tissue disease associated pulmonary hypertension.
    Arthritis Rheumatol. 2021 Feb 3. doi: 10.1002/art.41670.
    PubMed    
    Abstract available

  42. MARGELIDON-COZZOLINO V, Cottin V, Dupuis-Girod S, Traclet J, et al
    Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions.
    ERJ Open Res. 2021;7.
    PubMed    
    Abstract available

  43. ONISHI H, Taniguchi Y, Matsuoka Y, Yanaka K, et al
    Evaluation of microvasculopathy using dual-energy computed tomography in patients with chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2021;11:2045894020983162.
    PubMed    
    Abstract available

  44. ALBINNI S, Pavo I, Kitzmueller E, Michel-Behnke I, et al
    Macitentan in infants and children with pulmonary hypertensive vascular disease. Feasibility, tolerability and practical issues - a single-centre experience.
    Pulm Circ. 2021;11:2045894020979503.
    PubMed    
    Abstract available

  45. AMOR-GARCIA MA, Ibanez-Garcia S, Garcia-Gonzalez X, Mombiela T, et al
    Clinical evaluation of pulmonary hypertension using patient-reported outcomes: a cross-sectional study.
    BMC Pulm Med. 2021;21:48.
    PubMed    
    Abstract available

  46. ARJAANS S, Zwart EAH, Roofthooft M, Kooi EMW, et al
    Pulmonary hypertension in extremely preterm infants: a call to standardize echocardiographic screening and follow-up policy.
    Eur J Pediatr. 2021 Feb 2. pii: 10.1007/s00431-021-03931.
    PubMed    
    Abstract available

  47. MISHRA A, Lal A, Sahu KK, George AA, et al
    An Update on Pulmonary Hypertension in Coronavirus Disease-19 (COVID-19).
    Acta Biomed. 2020;91:e2020155.
    PubMed    
    Abstract available

  48. ROTZINGER DC, Rezaei-Kalantari K, Aubert JD, Qanadli SD, et al
    Pulmonary angioplasty: A step further in the continuously changing landscape of chronic thromboembolic pulmonary hypertension management.
    Eur J Radiol. 2021;136:109562.
    PubMed    
    Abstract available

  49. TRIANTAFYLLIDI H, Mpahara A, Mademli M, Mayer E, et al
    Chronic thromboembolic pulmonary hypertension due to an implantable cardioverter-defibrillator's lead thrombosis.
    Hellenic J Cardiol. 2021 Jan 29. pii: S1109-9666(21)00008.
    PubMed    


  50. MADONNA R
    Exploring the mechanisms of action of gliflozines in heart failure and possible implications in pulmonary hypertension.
    Vascul Pharmacol. 2021 Jan 30:106839. doi: 10.1016/j.vph.2021.106839.
    PubMed    
    Abstract available

  51. ODA S, Kidoh M, Nagayama Y, Nakaura T, et al
    Non-Invasive Imaging in Pulmonary Hypertension- Comprehensive Assessment Using Dual-Layer Spectral Computed Tomography.
    Circ J. 2021 Jan 30. doi: 10.1253/circj.CJ-20-1007.
    PubMed    


  52. HIRAM R, Provencher S
    Pulmonary Disease, Pulmonary Hypertension and Atrial Fibrillation.
    Card Electrophysiol Clin. 2021;13:141-153.
    PubMed    
    Abstract available

  53. ZHENG W, Wang Z, Jiang X, Zhao Q, et al
    Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives.
    J Med Chem. 2020;63:15153-15186.
    PubMed    
    Abstract available

  54. TAGLIARI AP, Perez-Camargo D, Taramasso M
    Tricuspid regurgitation: when is it time for surgery?
    Expert Rev Cardiovasc Ther. 2021;19:47-59.
    PubMed    
    Abstract available

  55. MAGOON R
    The pulmonary circuit dynamics in COVID-19!
    J Anesth. 2021;35:161.
    PubMed    


  56. PU X, Du L, Hu Y, Fan Y, et al
    Stem/Progenitor Cells and Pulmonary Arterial Hypertension.
    Arterioscler Thromb Vasc Biol. 2021;41:167-178.
    PubMed    
    Abstract available

  57. BALLASH GA, Schober KE, Haw SR, Shilo K, et al
    Idiopathic pulmonary arterial hypertension in a pot-bellied pig (Sus scrofa domesticus) with right-sided congestive heart failure.
    J Vet Cardiol. 2020;31:1-7.
    PubMed    
    Abstract available

  58. LAZAR Z, Meszaros M, Bikov A
    The Nitric Oxide Pathway in Pulmonary Arterial Hypertension: Pathomechanism, Biomarkers and Drug Targets.
    Curr Med Chem. 2020;27:7168-7188.
    PubMed    
    Abstract available

  59. LI Z, Qiao W, Wang C, Wang H, et al
    DPPC-coated lipid nanoparticles as an inhalable carrier for accumulation of resveratrol in the pulmonary vasculature, a new strategy for pulmonary arterial hypertension treatment.
    Drug Deliv. 2020;27:736-744.
    PubMed    
    Abstract available

  60. TURTON HA, Thompson AAR, Farkas L
    RNA Signaling in Pulmonary Arterial Hypertension-A Double-Stranded Sword.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  61. ZHOU S, Zhu K, Du Y, Jiang H, et al
    Estrogen administration reduces the risk of pulmonary arterial hypertension by modulating the miR-133a signaling pathways in rats.
    Gene Ther. 2020;27.
    PubMed    
    Abstract available

  62. LEUCHTE HH, Halank M, Held M, Borst M, et al
    [Differential Diagnosis of Pulmonary Hypertension Using the Example of Collagenosis-associated PAH in the Context of Chronic Lung and Left Heart Disease].
    Pneumologie. 2021;75:122-137.
    PubMed    
    Abstract available

  63. ONDA T, Manabe A, Akimoto T, Hayasaka I, et al
    Incidence of alveolar capillary dysplasia with misalignment of pulmonary veins in infants with unexplained severe pulmonary hypertension: The roles of clinical, pathological, and genetic testing.
    Early Hum Dev. 2021;155:105323.
    PubMed    
    Abstract available

  64. OKAMOTO S, Kondo Y, Sato K, Nishiyama T, et al
    Anti-PL-7 antibody positive antisynthetase syndrome diagnosed after the onset of pulmonary hypertension and right-sided heart failure.
    Rheumatology (Oxford). 2021 Feb 10. pii: 6133270.
    PubMed    


  65. WANG M, Luo P, Shi W, Guo J, et al
    S-Nitroso-L-Cysteine Ameliorated Pulmonary Hypertension in the MCT-Induced Rats through Anti-ROS and Anti-Inflammatory Pathways.
    Oxid Med Cell Longev. 2021;2021:6621232.
    PubMed    
    Abstract available

  66. TSUKADA J, Yamada Y, Kawakami T, Matsumoto S, et al
    Treatment effect prediction using CT after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
    Eur Radiol. 2021 Feb 10. pii: 10.1007/s00330-021-07711.
    PubMed    
    Abstract available

  67. LUO Q, Yu X, Zhao Z, Zhao Q, et al
    The value of cardiopulmonary exercise testing in the diagnosis of pulmonary hypertension.
    J Thorac Dis. 2021;13:178-188.
    PubMed    
    Abstract available

  68. NAKAYAMA R, Takaya Y, Nakamura K, Kondo M, et al
    Efficacy of shear wave elastography for evaluating right ventricular myocardial fibrosis in monocrotaline-induced pulmonary hypertension rats.
    J Cardiol. 2021 Feb 7. pii: S0914-5087(21)00028.
    PubMed    
    Abstract available

  69. AVITABILE CM, Saavedra S, Sivakumar N, Goldmuntz E, et al
    Marked skeletal muscle deficits are associated with 6-minute walk distance in paediatric pulmonary hypertension.
    Cardiol Young. 2021 Feb 11:1-8. doi: 10.1017/S1047951121000342.
    PubMed    
    Abstract available

  70. DAN K, Shionoda A, Matsubara H
    Systematic Staged Percutaneous Balloon Pulmonary Angioplasty in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension.
    Arq Bras Cardiol. 2021;116.
    PubMed    


  71. XU W, Janocha AJ, Erzurum SC
    Metabolism in Pulmonary Hypertension.
    Annu Rev Physiol. 2021;83:551-576.
    PubMed    
    Abstract available

  72. SAKAMAKI F, Asano K
    Pulmonary Hypertension Associated With Respiratory Diseases- Which Patients Should Be Treated With Pulmonary Arterial Hypertension-Targeted Therapies?
    Circ J. 2021 Feb 9. doi: 10.1253/circj.CJ-21-0030.
    PubMed    


  73. VARGHESE NP, Tillman RH, Keller RL
    Pulmonary hypertension is an important co-morbidity in developmental lung diseases of infancy: Bronchopulmonary dysplasia and congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2021;56:670-677.
    PubMed    
    Abstract available

  74. COLEMAN RD, Chartan CA, Mourani PM
    Intensive care management of right ventricular failure and pulmonary hypertension crises.
    Pediatr Pulmonol. 2021;56:636-648.
    PubMed    
    Abstract available

  75. MALLORY GB, Abman SH
    The many challenges to the field of pediatric pulmonology posed by pediatric pulmonary hypertension and the path forward.
    Pediatr Pulmonol. 2021;56:583-586.
    PubMed    


  76. WITKOWSKI A, Szumowski L, Urbanek P, Jastrzebski J, et al
    Transcatheter pulmonary denervation in patients with left heart failure with reduced ejection fraction and combined precapillary and postcapillary pulmonary hypertension: A prospective single center experience.
    Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29526.
    PubMed    
    Abstract available

  77. ACOSTA MF, Muralidhran P, Abrahamson MD, Grijalva CL, et al
    Comparison of L-Carnitine and L-Carnitine HCL Salt for Targeted Lung Treatment of Pulmonary Hypertension (PH) as Inhalation Aerosols: Design, Comprehensive Characterization, In Vitro 2D/3D Cell Cultures, and In Vivo MCT-Rat Model of PH.
    Pulm Pharmacol Ther. 2021 Feb 5:101998. doi: 10.1016/j.pupt.2021.101998.
    PubMed    
    Abstract available

  78. GHIO S, Crimi G, Houston B, Montalto C, et al
    Non-response to acute vasodilator challenge and prognosis in heart failure with pulmonary hypertension.
    J Card Fail. 2021 Feb 5. pii: S1071-9164(21)00049.
    PubMed    
    Abstract available

  79. SUMIMOTO K, Taniguchi Y, Emoto N, Hirata KI, et al
    Combination therapy with pulmonary arterial hypertension targeted drugs and immunosuppression can be a useful strategy for sarcoidosis-associated pulmonary hypertension: a case report.
    Eur Heart J Case Rep. 2020;5:ytaa454.
    PubMed    
    Abstract available

  80. ZHANG L, Bai Y, Yan P, He T, et al
    Balloon pulmonary angioplasty vs. pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.
    Heart Fail Rev. 2021 Feb 5. pii: 10.1007/s10741-020-10070.
    PubMed    
    Abstract available

  81. WANG L, Zhao LP, Chen Y, Chang X, et al
    Obesity paradox in pulmonary hypertension due to left ventricular systolic dysfunction.
    Herz. 2021 Feb 5. pii: 10.1007/s00059-021-05023.
    PubMed    
    Abstract available

  82. WAXMAN AB, Singh I
    Pulmonary Hypertension: An Integrative Approach to Assessment and Management.
    Clin Chest Med. 2021;42:xiii-xiv.
    PubMed    


  83. SINGH I, Horn E, Haythe J
    Pulmonary Hypertension in Pregnancy.
    Clin Chest Med. 2021;42:91-99.
    PubMed    
    Abstract available

  84. ROSENZWEIG EB, Krishnan U
    Congenital Heart Disease-Associated Pulmonary Hypertension.
    Clin Chest Med. 2021;42:9-18.
    PubMed    
    Abstract available

  85. LANG IM, Campean IA, Sadushi-Kolici R, Badr-Eslam R, et al
    Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension.
    Clin Chest Med. 2021;42:81-90.
    PubMed    
    Abstract available

  86. SHIOLENO AM, Ruopp NF
    Group 3 Pulmonary Hypertension: A Review of Diagnostics and Clinical Trials.
    Clin Chest Med. 2021;42:59-70.
    PubMed    
    Abstract available

  87. REDDY YNV, Borlaug BA
    Pulmonary Hypertension in Left Heart Disease.
    Clin Chest Med. 2021;42:39-58.
    PubMed    
    Abstract available

  88. MORRIS H, Denver N, Gaw R, Labazi H, et al
    Sex Differences in Pulmonary Hypertension.
    Clin Chest Med. 2021;42:217-228.
    PubMed    
    Abstract available

  89. WILKINS MR
    Personalized Medicine for Pulmonary Hypertension:: The Future Management of Pulmonary Hypertension Requires a New Taxonomy.
    Clin Chest Med. 2021;42:207-216.
    PubMed    
    Abstract available

  90. MULLIN CJ, Ventetuolo CE
    Critical Care Management of the Patient with Pulmonary Hypertension.
    Clin Chest Med. 2021;42:155-165.
    PubMed    
    Abstract available

  91. FOUAD J, Joseph P
    The Evolution in Nomenclature, Diagnosis, and Classification of Pulmonary Hypertension.
    Clin Chest Med. 2021;42:1-8.
    PubMed    
    Abstract available

  92. LI G, Zhang H, Fan X, Su J, et al
    Pulmonary artery banding in patients with functional single ventricle associated with pulmonary hypertension.
    Clin Exp Hypertens. 2021 Feb 5:1-6. doi: 10.1080/10641963.2021.1883048.
    PubMed    
    Abstract available

  93. KIMMELSTIEL C, Resor CD
    Transcatheter Tricuspid Valve Intervention in Right Ventricular Dysfunction and Pulmonary Hypertension: Wrongly Forgotten or Appropriately Ignored?
    Circ Cardiovasc Interv. 2021 Feb 5:CIRCINTERVENTIONS121010482.
    PubMed    


  94. MUNTANE-CAROL G, Taramasso M, Miura M, Gavazzoni M, et al
    Transcatheter Tricuspid Valve Intervention in Patients With Right Ventricular Dysfunction or Pulmonary Hypertension: Insights From the TriValve Registry.
    Circ Cardiovasc Interv. 2021 Feb 5:CIRCINTERVENTIONS120009685.
    PubMed    
    Abstract available

  95. PARK JF, Clark VR, Banerjee S, Hong J, et al
    Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of EMT in Human Right Ventricular Failure.
    Circ Heart Fail. 2021 Feb 5:CIRCHEARTFAILURE120007058.
    PubMed    
    Abstract available

  96. VEEROJU S, Kojonazarov B, Weiss A, Ghofrani HA, et al
    Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  97. AUSTIN ED
    Sex Hormones across the Menstrual Cycle in Pulmonary Arterial Hypertension: Adding a New Layer of Complexity.
    Ann Am Thorac Soc. 2021;18:209-211.
    PubMed    


  98. TRITTMANN JK
    Keratin 1: A negative regulator of inflammation and potential treatment for pulmonary arterial hypertension.
    Acta Physiol (Oxf). 2021;231:e13594.
    PubMed    


  99. YANG J, Griffiths M, Nies MK, Brandal S, et al
    Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.
    BMC Med. 2020;18:268.
    PubMed    
    Abstract available

  100. DENG L, Chen J, Wang T, Chen B, et al
    PDGF/MEK/ERK axis represses Ca(2+) clearance via decreasing the abundance of plasma membrane Ca(2+) pump PMCA4 in pulmonary arterial smooth muscle cells.
    Am J Physiol Cell Physiol. 2021;320:C66-C79.
    PubMed    
    Abstract available

  101. LAZZERI C, Bonizzoli M, Batacchi S, Peris A, et al
    Echocardiographic assessment of the right ventricle in COVID -related acute respiratory syndrome.
    Intern Emerg Med. 2021;16:1-5.
    PubMed    
    Abstract available

  102. NAGATA A, Tagashira H, Kita S, Kita T, et al
    Genetic knockout and pharmacologic inhibition of NCX1 attenuate hypoxia-induced pulmonary arterial hypertension.
    Biochem Biophys Res Commun. 2020;529:793-798.
    PubMed    
    Abstract available

  103. ALJOHANI OA, Rao R, Mackie D, Haldeman S, et al
    Combination of PGE1 and Pulmonary Vasodilator Therapy in Managing a Challenging Case of Severe PAH Secondary to CDH.
    World J Pediatr Congenit Heart Surg. 2020;11:525-527.
    PubMed    
    Abstract available

  104. LI T, Li S, Feng Y, Zeng X, et al
    Combination of Dichloroacetate and Atorvastatin Regulates Excessive Proliferation and Oxidative Stress in Pulmonary Arterial Hypertension Development via p38 Signaling.
    Oxid Med Cell Longev. 2020;2020:6973636.
    PubMed    
    Abstract available

  105. SIMENAUER A, Nozik-Grayck E, Cota-Gomez A
    The DNA Damage Response and HIV-Associated Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  106. GOJKOVIC M, Velica P, Rundqvist H, Johnson RS, et al
    Response to Swenson and Bartsch.
    Acta Physiol (Oxf). 2021;231:e13494.
    PubMed    


  107. AYPAR E, Alehan D, Karagoz T, Aykan H, et al
    Clinical efficacy and safety of switch from bosentan to macitentan in children and young adults with pulmonary arterial hypertension: extended study results.
    Cardiol Young. 2020;30:681-685.
    PubMed    
    Abstract available

  108. ALSALMAN F, Howlett M, Breatnach C, Kelly H, et al
    Supporting the use of sildenafil infusions in paediatric and neonatal intensive care - A compatibility study.
    Eur J Pharm Biopharm. 2020;151:153-161.
    PubMed    
    Abstract available

  109. YU M, Peng L, Liu P, Yang M, et al
    Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition.
    Drug Des Devel Ther. 2020;14:1191-1202.
    PubMed    
    Abstract available

  110. SADD CJ, Osman F, Li Z, Chybowski A, et al
    Long-term Outcomes and Survival in Moderate-Severe Portopulmonary Hypertension After Liver Transplant.
    Transplantation. 2020 Mar 30. doi: 10.1097/TP.0000000000003248.
    PubMed    
    Abstract available

  111. WANG Y, Zhong B, Wu Q, Zhu T, et al
    Aldosterone Contributed to Pulmonary Arterial Hypertension Development via Stimulating Aquaporin Expression and Pulmonary Arterial Smooth Muscle Cells Proliferation.
    Pharmacology. 2020;105.
    PubMed    
    Abstract available

  112. DONATI S, Maresca AM, Cattaneo J, Grossi A, et al
    Optical coherence tomography angiography and arterial hypertension: A role in identifying subclinical microvascular damage?
    Eur J Ophthalmol. 2019 Oct 16:1120672119880390. doi: 10.1177/1120672119880390.
    PubMed    
    Abstract available

  113. KAWADA T
    N-terminal pro-B-type natriuretic peptide, pulmonary hypertension and cardiac dysfunction in patients with congenital diaphragmatic hernia.
    Early Hum Dev. 2021;155:105332.
    PubMed    


  114. GENUARDI MV, Shpilsky D, Handen A, VanSpeybroeck G, et al
    Increased Mortality in Patients With Preoperative and Persistent Postoperative Pulmonary Hypertension Undergoing Mitral Valve Surgery for Mitral Regurgitation: A Cohort Study.
    J Am Heart Assoc. 2021 Feb 18:e018394. doi: 10.1161/JAHA.120.018394.
    PubMed    
    Abstract available

  115. SABRI MR, Mahdavi C, Bigdelian H, Ahmadi AR, et al
    A case series of pulmonary hypertension in small infants with atrial septal defect.
    ARYA Atheroscler. 2020;16:208-210.
    PubMed    
    Abstract available

  116. NTOKOU A, Dave JM, Kauffman AC, Sauler M, et al
    Macrophage-derived PDGF-B induces muscularization in murine and human pulmonary hypertension.
    JCI Insight. 2021 Feb 16. pii: 139067. doi: 10.1172/jci.insight.139067.
    PubMed    
    Abstract available

  117. GIUCA A, Raileanu V, Capsa R, Popescu BA, et al
    Parkes-Weber Syndrome and double orifice atrial septal defect as a combined rare cause of severe pulmonary hypertension.
    Int J Cardiovasc Imaging. 2021 Feb 15. pii: 10.1007/s10554-021-02185.
    PubMed    


  118. OZGUVEN S, Kesim S, Oksuzoglu K, Yanartas M, et al
    Correlation Between Perfusion Abnormalities Extent in Ventilation/Perfusion SPECT/CT with Hemodynamic Parameters in Patients with Chronic Thromboembolic Pulmonary Hypertension
    Mol Imaging Radionucl Ther. 2021;30:28-33.
    PubMed    
    Abstract available

  119. ALHUZAIMI AN, Alotaibi NM, Alsuhaibani GI, Alanazi RK, et al
    Congenital Heart Defect and Pulmonary Hypertension in Children With Down Syndrome: Clinical Profile Over Two Decades.
    Cureus. 2021;13:e13212.
    PubMed    
    Abstract available

  120. IKEDA N, Amemiya K, Sato S, Iijima R, et al
    Evolution of patients with chronic thromboembolic pulmonary hypertension treated by balloon pulmonary angioplasty, according to their anticoagulant regimens.
    Heart Vessels. 2021 Feb 13. pii: 10.1007/s00380-021-01799.
    PubMed    
    Abstract available

  121. TERAMACHI R, Taniguchi H, Kondoh Y, Kimura T, et al
    Impact of post-capillary pulmonary hypertension on mortality in interstitial lung disease.
    Respir Investig. 2021 Feb 9. pii: S2212-5345(21)00007.
    PubMed    
    Abstract available

  122. SYDYKOV A, Mamazhakypov A, Maripov A, Kosanovic D, et al
    Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  123. KOH CH
    Commercial Air Travel for Passengers With Cardiovascular Disease: Recommendations for Less Common Conditions, Considerations for Venous Thromboembolism, and General Guidance.
    Curr Probl Cardiol. 2021;46:100782.
    PubMed    
    Abstract available

  124. SCUDIERO F, Silverio A, Di Maio M, Russo V, et al
    Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome.
    Thromb Res. 2020;198:34-39.
    PubMed    
    Abstract available

  125. CARAVITA S, Baratto C, Di Marco F, Calabrese A, et al
    Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization.
    Eur J Heart Fail. 2020;22:2228-2237.
    PubMed    
    Abstract available

  126. SANCHEZ-GLORIA JL, Osorio-Alonso H, Arellano-Buendia AS, Carbo R, et al
    Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  127. SUN Q, Hackler J, Hilger J, Gluschke H, et al
    Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Nutrients. 2020;12.
    PubMed    
    Abstract available

  128. BRUNI C, De Luca G, Lazzaroni MG, Zanatta E, et al
    Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review.
    Eur J Intern Med. 2020;78:17-25.
    PubMed    
    Abstract available

  129. WILSON WM, Shah A, Osten MD, Benson LN, et al
    Clinical Outcomes After Percutaneous Patent Ductus Arteriosus Closure in Adults.
    Can J Cardiol. 2020;36:837-843.
    PubMed    
    Abstract available

  130. ZENG Q, Yang H, Liu B, Ma Y, et al
    Clinical characteristics and survival of Chinese patients diagnosed with pulmonary arterial hypertension who carry BMPR2 or EIF2KAK4 variants.
    BMC Pulm Med. 2020;20:150.
    PubMed    
    Abstract available

  131. SIMPSON LL, Meah VL, Steele A, Thapamagar S, et al
    Evidence for a physiological role of pulmonary arterial baroreceptors in sympathetic neural activation in healthy humans.
    J Physiol. 2020;598:955-965.
    PubMed    
    Abstract available

  132. FRIED ND, Morris TM, Whitehead A, Lazartigues E, et al
    Angiotensin-II type 1 receptor mediates pulmonary hypertension and right ventricular remodeling induced by inhaled nicotine.
    Am J Physiol Heart Circ Physiol. 2021 Feb 12. doi: 10.1152/ajpheart.00883.2020.
    PubMed    
    Abstract available

  133. VALUPARAMPIL VARGHESE M, James J, Rafikova O, Rafikov R, et al
    Glucose-6 Phosphate dehydrogenase deficiency contributes to metabolic abnormality and pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2021 Jan 27. doi: 10.1152/ajplung.00165.2020
    PubMed    
    Abstract available

  134. RODRIGUEZ-LOPEZ J, Wright CD, Stone JR, Farber H, et al
    When Imaging in Chronic Thromboembolic Pulmonary Hypertension Is Not Enough.
    Am J Respir Crit Care Med. 2021;203:e3-e4.
    PubMed    


  135. SYNN AJ, Li W, San Jose Estepar R, Washko GR, et al
    Pulmonary Vascular Pruning on Computed Tomography and Risk of Death in the Framingham Heart Study.
    Am J Respir Crit Care Med. 2021;203:251-254.
    PubMed    


  136. FANOURIAKIS A, Tziolos N, Bertsias G, Boumpas DT, et al
    Update omicronn the diagnosis and management of systemic lupus erythematosus.
    Ann Rheum Dis. 2021;80:14-25.
    PubMed    
    Abstract available

  137. MARON BA
    Rebuttal From Dr Maron.
    Chest. 2020;157:769-770.
    PubMed    


  138. FRANTZ RP
    Rebuttal From Dr Frantz.
    Chest. 2020;157:768-769.
    PubMed    


  139. WHITE RJ, Lachant DJ
    Selexipag Use in Clinical Practice: Mind the Gap.
    Chest. 2020;157:761-763.
    PubMed    


  140. BRACK T
    Into Thin Air: A Step Forward to Counsel Patients With Pulmonary Hypertension Travelling to High Altitude.
    Chest. 2021;159:484-485.
    PubMed    


  141. TISSOT N, Montani D, Seronde MF, Degano B, et al
    Venoocclusive Disease With Both Hepatic and Pulmonary Involvement.
    Chest. 2020;157:e107-e109.
    PubMed    
    Abstract available

  142. FRANTZ RP
    COUNTERPOINT: Should the New Definition of PH Be the Clinical Practice Standard? No.
    Chest. 2020;157:766-768.
    PubMed    


  143. MARON BA
    POINT: Should the New Definition of PH Be the Clinical Practice Standard? Yes.
    Chest. 2020;157:764-766.
    PubMed    


  144. HACHULLA E, Launay D, Boucly A, Mouthon L, et al
    Survival Improved in Patients Aged
    Chest. 2020;157:945-954.
    PubMed    
    Abstract available

  145. MCLAUGHLIN VV, Channick R, De Marco T, Farber HW, et al
    Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway Agents.
    Chest. 2020;157:955-965.
    PubMed    
    Abstract available

  146. VIZZA CD, Hoeper MM, Huscher D, Pittrow D, et al
    Pulmonary hypertension in patients with chronic obstructive lung disease: results from COMPERA.
    Chest. 2021 Feb 10. pii: S0012-3692(21)00272-5. doi: 10.1016/j.chest.2021.
    PubMed    
    Abstract available

  147. HAARMAN MG, Kerstjens-Frederikse WS, Berger RMF
    TBX4 variants and pulmonary diseases: getting out of the 'Box'.
    Curr Opin Pulm Med. 2020;26:277-284.
    PubMed    
    Abstract available

  148. BADAGLIACCA R, Vizza CD
    Imaging risk in pulmonary arterial hypertension.
    Eur Respir J. 2020;56.
    PubMed    


  149. THORE P, Girerd B, Jais X, Savale L, et al
    Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation.
    Eur Respir J. 2020;55.
    PubMed    
    Abstract available

  150. GHIO S, Crimi G, Guida S, Valentini A, et al
    Magnetic resonance imaging of pulmonary arterial compliance after pulmonary endarterectomy.
    Eur Respir J. 2020;55.
    PubMed    


  151. GERGES C, Vollmers K, Pritzker MR, Gainor J, et al
    Pulmonary Artery Endovascular Device Compensates for Loss of Vascular Compliance in Pulmonary Arterial Hypertension.
    J Am Coll Cardiol. 2020;76:2284-2286.
    PubMed    


  152. SMELTZ AM, Kumar PA
    Pro: General Anesthesia Is Superior to Regional Anesthesia for Patients with Pulmonary Hypertension Undergoing Noncardiac Surgery.
    J Cardiothorac Vasc Anesth. 2021 Jan 7. pii: S1053-0770(21)00003.
    PubMed    


  153. KESTING AC, Hansmann G, Sallmon H
    Toward a standardized multidisciplinary team approach in preterm infants at-risk for pulmonary hypertension.
    J Perinatol. 2021 Feb 9. pii: 10.1038/s41372-021-00949.
    PubMed    


  154. ALEEM S, Robbins C, Murphy B, Elliott S, et al
    The use of supplemental hydrocortisone in the management of persistent pulmonary hypertension of the newborn.
    J Perinatol. 2021 Feb 15. pii: 10.1038/s41372-021-00943.
    PubMed    
    Abstract available

  155. MAT BAH MN, Tan RYH, Razak H, Sapian MH, et al
    Survival and associated risk factors for mortality among infants with persistent pulmonary hypertension of the newborn in Malaysia.
    J Perinatol. 2021 Feb 15. pii: 10.1038/s41372-021-00962.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;